Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.

Du H, Xu Q, Xiao S, Wu Z, Gong J, Liu C, Ren G, Wu H.

Life Sci. 2019 May 1;224:1-11. doi: 10.1016/j.lfs.2019.03.028. Epub 2019 Mar 12.

PMID:
30876939
2.

MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.

Fang F, Chang RM, Yu L, Lei X, Xiao S, Yang H, Yang LY.

J Hepatol. 2015 Oct;63(4):874-85. doi: 10.1016/j.jhep.2015.05.008. Epub 2015 May 18.

PMID:
25998163
3.

Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.

Li WF, Dai H, Ou Q, Zuo GQ, Liu CA.

Tumour Biol. 2016 May;37(5):5885-95. doi: 10.1007/s13277-015-4456-1. Epub 2015 Nov 21.

PMID:
26589417
4.

Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1.

Wang YG, Wang T, Shi M, Zhai B.

J Exp Clin Cancer Res. 2019 Apr 10;38(1):153. doi: 10.1186/s13046-019-1128-9.

5.

Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.

Ma J, Li T, Han X, Yuan H.

J Cancer Res Clin Oncol. 2018 Feb;144(2):205-214. doi: 10.1007/s00432-017-2543-y. Epub 2017 Nov 10.

PMID:
29127494
6.

MiR-877-5p suppresses cell growth, migration and invasion by targeting cyclin dependent kinase 14 and predicts prognosis in hepatocellular carcinoma.

Yan TH, Qiu C, Sun J, Li WH.

Eur Rev Med Pharmacol Sci. 2018 May;22(10):3038-3046. doi: 10.26355/eurrev_201805_15061.

7.

MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1.

Li Y, Bai W, Zhang J.

Biomed Pharmacother. 2017 Aug;92:1038-1044. doi: 10.1016/j.biopha.2017.05.092. Epub 2017 Jun 10.

PMID:
28609841
8.

miR-296-5p suppresses EMT of hepatocellular carcinoma via attenuating NRG1/ERBB2/ERBB3 signaling.

Shi DM, Li LX, Bian XY, Shi XJ, Lu LL, Zhou HX, Pan TJ, Zhou J, Fan J, Wu WZ.

J Exp Clin Cancer Res. 2018 Nov 29;37(1):294. doi: 10.1186/s13046-018-0957-2.

9.

miR-155-5p modulates malignant behaviors of hepatocellular carcinoma by directly targeting CTHRC1 and indirectly regulating GSK-3β-involved Wnt/β-catenin signaling.

Chen G, Wang D, Zhao X, Cao J, Zhao Y, Wang F, Bai J, Luo D, Li L.

Cancer Cell Int. 2017 Dec 8;17:118. doi: 10.1186/s12935-017-0469-8. eCollection 2017.

10.

MicroRNA-30a-5p suppresses proliferation, invasion and tumor growth of hepatocellular cancer cells via targeting FOXA1.

Zhang S, Liu Q, Zhang Q, Liu L.

Oncol Lett. 2017 Oct;14(4):5018-5026. doi: 10.3892/ol.2017.6745. Epub 2017 Aug 10.

11.

miR-106b-5p promotes stem cell-like properties of hepatocellular carcinoma cells by targeting PTEN via PI3K/Akt pathway.

Shi DM, Bian XY, Qin CD, Wu WZ.

Onco Targets Ther. 2018 Jan 26;11:571-585. doi: 10.2147/OTT.S152611. eCollection 2018.

12.

MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.

Huang XP, Hou J, Shen XY, Huang CY, Zhang XH, Xie YA, Luo XL.

FEBS J. 2015 Feb;282(3):579-94. doi: 10.1111/febs.13167. Epub 2014 Dec 27.

13.

Increased expression of microRNA-31-5p inhibits cell proliferation, migration, and invasion via regulating Sp1 transcription factor in HepG2 hepatocellular carcinoma cell line.

Zhao G, Han C, Zhang Z, Wang L, Xu J.

Biochem Biophys Res Commun. 2017 Aug 19;490(2):371-377. doi: 10.1016/j.bbrc.2017.06.050. Epub 2017 Jun 13.

14.

Role of miR-16-5p in the proliferation and metastasis of hepatocellular carcinoma.

Cheng B, Ding F, Huang CY, Xiao H, Fei FY, Li J.

Eur Rev Med Pharmacol Sci. 2019 Jan;23(1):137-145. doi: 10.26355/eurrev_201901_16757.

15.

miRNA-320a inhibits tumor proliferation and invasion by targeting c-Myc in human hepatocellular carcinoma.

Xie F, Yuan Y, Xie L, Ran P, Xiang X, Huang Q, Qi G, Guo X, Xiao C, Zheng S.

Onco Targets Ther. 2017 Feb 15;10:885-894. doi: 10.2147/OTT.S122992. eCollection 2017.

16.

MicroRNA-214-5p Inhibits the Invasion and Migration of Hepatocellular Carcinoma Cells by Targeting Wiskott-Aldrich Syndrome Like.

Li H, Wang H, Ren Z.

Cell Physiol Biochem. 2018;46(2):757-764. doi: 10.1159/000488734. Epub 2018 Mar 29.

17.

MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.

Fu X, Wen H, Jing L, Yang Y, Wang W, Liang X, Nan K, Yao Y, Tian T.

Cancer Sci. 2017 Apr;108(4):620-631. doi: 10.1111/cas.13177. Epub 2017 Apr 19.

18.

Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion.

Shen Q, Cicinnati VR, Zhang X, Iacob S, Weber F, Sotiropoulos GC, Radtke A, Lu M, Paul A, Gerken G, Beckebaum S.

Mol Cancer. 2010 Aug 27;9:227. doi: 10.1186/1476-4598-9-227.

19.

miR-589-5p inhibits MAP3K8 and suppresses CD90+ cancer stem cells in hepatocellular carcinoma.

Zhang X, Jiang P, Shuai L, Chen K, Li Z, Zhang Y, Jiang Y, Li X.

J Exp Clin Cancer Res. 2016 Nov 11;35(1):176.

20.

MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma.

Chen JS, Li HS, Huang JQ, Dong SH, Huang ZJ, Yi W, Zhan GF, Feng JT, Sun JC, Huang XH.

Cancer Lett. 2016 May 28;375(1):73-83. doi: 10.1016/j.canlet.2016.02.043. Epub 2016 Mar 2.

PMID:
26944318

Supplemental Content

Support Center